Project Description

The European Training Network (ETN) project NanoCarb has been funded as an Innovative Training Network (ITN) under the Marie Skłodowska-Curie Actions (MSCA) of Horizon 2020. The overarching aim of the NanoCarb ETN project is to develop glycosylated nanoparticles with enhanced therapeutic actions for healthcare applications. 15 Early Stage Researchers (ESRs) recruited for the NanoCarb project will work on their individual ESR projects designed to provide appropriate research goals for PhD students. Each ESR will be exposed to a well-balanced and optimal experience in academia, industry and research centre in order to increase their research experience and scientific maturity.

Abstract

Nanotechnology is one of the primary drivers of technology innovation, and it is one of the leading pillars of the six Key Enabling Technologies of Horizon 2020. Among the different application scopes of nanotechnology, its use in medicine has attracted considerable attention for its potential advances in healthcare, personalised medicine and to tackle complex issues such as the targeted and programmed delivery of drugs. The birth of nanomedicine required integration of different research field, such as nanoscience, physics, chemistry, modern pharmacy and clinical practice into a unique multidisciplinary research topic, all of which will be applied in the context of NanoCarb.

The overall aim of the NanoCarb ETN is to train a new generation of creative and innovative multidisciplinary early-stage researchers in the fields of nanotechnology and carbohydrate chemistry through an integrated research training programme in academia, industry and research centre environments. At the end of this project, the ESRs expertise will make them excellent candidates for a career in academia or industrial sectors.

 

Our Role

accelopment is a Partner Organisation in NanoCarb. We are involved in three areas of the project – assisting in project management tasks, coordinating the communication and dissemination activities and contributing to the ESR training activities with a Transferable skills course.

Project Details

Coordinator: 
Partners: 
accelopment AG, CH
Royal College of Surgeons in Ireland, IE
University of Warwick, UK
Università degli Studi di Milano, IT
CIC biomaGUNE, ES
Vlaamse Instelling voor Technologisch Onderzoek, BE
Ludger Ltd, UK
Midatech Pharma, UK
Istituto di Ricerche Farmacologiche Mario Negri, IT
Horizons Unleashed Ltd, UK
Attana AB, SE
MJR PharmaJet GmbH, DE
Fundacao da Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa, PT
Universiteit Hasselt, BE
University of the Basque Country, ES
Malvern Panalytical, UK
Consiglio Nazionale delle Ricerche, IT
Contact: 
Duration: 
01.10.2018 - 30.09.2022
Budget: 
4.2 million euro
Our Services: 
Proposal Writing
Contract Negotiations
Project Management
Project Dissemination
Funding Programme: 
  • H2020-MSCA-ITN
Area: 
Chemistry